Gastrointestinal bleeding: Difference between revisions

(Created page with "==Workup== ER 0) 2 large bore IV 1) Icon 2) CBC & serial Hb 3) Chem 7 (BUN/Cr >35 suggests UGI if no hx of RF) 4) T&S/T&C 5) Coags (if INR > 1.5 transfuse FFP) 6) ?Guiac...")
 
(Add References)
 
(20 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Workup==
<languages/>
 
<translate>
 
</translate>
ER
{{GI bleeding pages}}
 
<translate>
0) 2 large bore IV
 
1) Icon
 
2) CBC & serial Hb
 
3) Chem 7 (BUN/Cr >35 suggests UGI if no hx of RF)
 
4) T&S/T&C
 
5) Coags (if INR > 1.5 transfuse FFP)
 
6) ?Guiac
 
7) LFTs/lipase
 
8) *CXR if sx perf (diff TTP abd)
 
9) *ECG (if >50 yo or if suspicious for silent MI)
 
11) NG lavage (controversial)
 
12) IVF/blood
 
13) IV PPI (Protonix 40-80mg x 1, then 8mg/hr)
 
14) Octreotide (suspected varices: 50mcg bolus, then 25mcg/hr)
 
15) Ceftriaxone (if e/o ascites; decreases mortality)
 
16) *Consider vasopressin/sengstaken-blakemore tube if no access to endoscopy
 
*If aortic graft --> immed surg consult
 
 
Consider
 
-Proctoscopy (22cm from anal verge)
 
-Sigmoidoscopy (60cm from anal verge)
 
-Angiography (requries arterial bledding >0.5cc/min)
 
-CT angio
 
== ==
 
 
==DDX==
 
 
===Adult===
 
 
-UGIB-
 
PUD (Gastric 21%, Duodenal 24%)
 
Gastritis 23%
 
Esophagitis/Duodenitis 6%
 
Varicies
 
Mallory-Weiss < 15%
 
Boerhaave's
 
Dieulafoy lesion
 
Angiodysplasia
 
Hemobilia
 
Aortoenteric fistula
 
 
-LGIB-
 
Upper GI bleed
 
Diverticulosis (painless, voluminous)
 
Infectious (virus, bacteria, parasites, C. dif)
 
Ischemic Colitis 3-12% (acute onset; 90% > 70yo)
 
IBD (fistula-in-ano)
 
Mesenteric Vascular Insufficiency (abd pain out of proportion to PE)
 
Angiodysplasia
 
Cancer/polyps
 
Rectal dz
 
Hemorrhoids
 
    External (below pectinate); Internal (above)
 
Ulcer (HIV, syphilis, STDs)
 
Fissures (painful defecation)
 
Abscess, prolapse, proctitis, impaction
 
 
===Peds===
 
 
-UGIB-
 
Esophagitis
 
Gastritis
 
Ulcer
 
Esophageal varices
 
Mallory-Weiss
 
 
-LGIB-
 
Anal fissure
 
Infectious colitis
 
IBDPolyps
 
Intussusception
 
 
==Disposition==
 
 
Blatchford score
 
Rockall score
 
 
-Home (very low risk)-
 
No comorbid dz
 
Normal vitals
 
Norma/trace pos guiac
 
Normal/near-normal Hb
 
Home support
 
F/U within 24hrs
 
 
-Ward/Stable (low risk)-
 
Age <60
 
Initial SBP >100
 
Normal vitals x 1hr
 
No transfusion req
 
No major comorbid
 
No liver dz
 
 
-ICU-
 
Normal or dec Hct
 
Blood in NG doesn't clear
 
SBP<100, HR>100
 
Gauaic +/- stool
 
 
==False Positive Guaiac==
 
 
Red fruits and meats
 
(Bananas, turnips, broccoli)
 
Methylene blue
 
Chlorophyll
 
Iodide
 
Cupric sulfate
 
Bromide
 
Iron (causes GI bleed by irritation)
 
 
==Source ==
 
 
3/12/06 DONALDSON (adapted from Rosen), Kaji
 


== Calculators ==
{{Glasgow_Blatchford_Calculator}}


==References==
<references/>


[[Category:GI]]
[[Category:GI]]
[[Category:Symptoms]]
</translate>

Latest revision as of 09:29, 22 March 2026


Gastrointestinal Bleeding Pages

Calculators

Glasgow-Blatchford Bleeding Score

Glasgow-Blatchford Bleeding Score (GBS)
Criteria Select
BUN (mg/dL) 1 <18.2 (0)   18.2–22.3 (+2)   22.4–27.9 (+3)   28–69.9 (+4)   ≥70 (+6)
Hemoglobin — Male (g/dL) 1 ≥13 (0)   12–12.9 (+1)   10–11.9 (+3)   <10 (+6)
Hemoglobin — Female (g/dL) 1 ≥12 (0)   10–11.9 (+1)   <10 (+6)
Systolic BP (mmHg) 1 ≥110 (0)   100–109 (+1)   90–99 (+2)   <90 (+3)
Heart rate ≥100 (+1) 1 No   Yes
Melena (+1) 1 No   Yes
Syncope (+2) 1 No   Yes
Hepatic disease (+2) 1 No   Yes
Cardiac failure (+2) 1 No   Yes
GBS Score / 23
Interpretation
0 Very low risk — Can be considered for outpatient management. Virtually 0% chance of needing intervention.
1‒11 Moderate risk — Consider inpatient management and endoscopy.
≥12 High risk — Urgent intervention likely needed.
References
  • Blatchford O, et al. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356(9238):1318-1321. PMID 11073021.
  • Stanley AJ, et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet. 2009;373(9657):42-47. PMID 19091393.

References